scispace - formally typeset
M

Makoto Hiramatsu

Researcher at Okayama University

Publications -  56
Citations -  874

Makoto Hiramatsu is an academic researcher from Okayama University. The author has contributed to research in topics: Peritoneal dialysis & Kidney disease. The author has an hindex of 13, co-authored 55 publications receiving 809 citations.

Papers
More filters
Journal ArticleDOI

2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease

TL;DR: The Japanese Society for Dialysis Therapy guideline committee, chaired by Dr Y. Tsubakihara, presents the Japanese guidelines, which replace the “2004 JSDT Guidelines for Renal Anemia in Chronic Hemodialysis Patients,” and contain new, additional guidelines for peritoneal dialysis, non‐dialysis (ND), and pediatric chronic kidney disease (CKD) patients.
Journal ArticleDOI

Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes

TL;DR: Serum levels of IL-18 might be a predictor of progression of diabetic nephropathy as well as cardiovascular diseases and changes in AER during the follow-up period are evaluated.
Journal ArticleDOI

Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR)

Hitoshi Yokoyama, +48 more
TL;DR: Renal biopsy is a valuable diagnostic tool, even in elderly and very elderly Japanese patients, and modified clinical guidelines for elderly renal disease should be developed.
Journal ArticleDOI

Microinflammation is a common risk factor for progression of nephropathy and atherosclerosis in Japanese patients with type 2 diabetes

TL;DR: The results suggest that low-grade inflammation, microinflammation, may be a common risk factor for diabetic nephropathy and atherosclerosis in Japanese type 2 diabetic patients.
Journal ArticleDOI

How to improve survival in geriatric peritoneal dialysis patients.

TL;DR: This study reviewed the experience with patients 65 years of age and older at the start of PD and the results from two multicenter studies on PD treatment in elderly patients in Japan, finding factors that have the potential to influence prognosis in these patients.